Results 11 to 20 of about 3,938 (215)

The Treatment of Tetanus with Intrathecal Baclofen [PDF]

open access: yesAnaesthesia and Intensive Care, 2000
The treatment of severe tetanus generally requires prolonged mechanical ventilation. We describe two cases managed with continuous intrathecal infusion of baclofen via a subcutaneous tunnelled spinal catheter and an abdominal injection port. Baclofen, by diminishing spasms and spasticity, allowed reduced sedation and paralysis requirements.
Boots, RJ   +4 more
openaire   +5 more sources

Status dystonicus resembling the intrathecal baclofen withdrawal syndrome: a case report and review of the literature

open access: yesJournal of Medical Case Reports, 2010
Introduction Status dystonicus is a rare but life-threatening disorder characterized by increasingly frequent and severe episodes of generalized dystonia that may occur in patients with primary or secondary dystonia.
Muirhead William   +2 more
doaj   +2 more sources

Intrathecal baclofen in metachromatic leukodystrophy [PDF]

open access: yesDevelopmental Medicine & Child Neurology, 2018
Metachromatic leukodystrophy (MLD) is a rare progressive neurological disorder, often accompanied by motor impairments that are challenging to treat. In this case series, we report the course of treatment with intrathecal baclofen (ITB), aimed at improving daily care and comfort in children and young adults with MLD. All patients with MLD in our centre
Nikki van der Veldt   +7 more
openaire   +3 more sources

Continuous intrathecal baclofen delivery in severely disabling spasticity [PDF]

open access: yesVojnosanitetski Pregled, 2018
Background/Aim. Spasticity is the consequence of several clinical conditions including cerebral palsy, brain injury, spinal cord injury, multiple sclerosis, aneurysm bleeding, and some other neurological disorders.
Simsek Hakan   +4 more
doaj   +3 more sources

Intrathecal baclofen pump, useful and safe therapeutic intervention in spasticity? Report of four cases

open access: yesIatreia, 2016
Spasticity may cause immobility, prostration, chronic pain, bedsores, infections, thrombosis and pneumonia; the purposes of its treatment are to control pain, improve mobility and quality of life, and reincorporate the patient to its daily activities by ...
Cáceres-Jerez, Luz Elena   +2 more
doaj   +2 more sources

A pediatric case of generalized tetanus treated with intrathecal baclofen

open access: yesToxicology Communications
Introduction Generalized tetanus from Clostridium tetani infections is rare in the United States due to widespread use of tetanus toxoid-containing vaccines, and management of these critically ill patients can be challenging.
Elizabeth M. Silver   +3 more
doaj   +2 more sources

Baclofen therapeutics, toxicity, and withdrawal: A narrative review

open access: yesSAGE Open Medicine, 2021
Baclofen is an effective therapeutic for the treatment of spasticity related to multiple sclerosis, spinal cord injuries, and other spinal cord pathologies.
Jia W Romito   +7 more
doaj   +1 more source

Spinal anesthesia for cesarean section in a woman with an intrathecal baclofen pump

open access: yesJA Clinical Reports, 2022
Background Intrathecal baclofen pumps are commonly used for the management of lower extremity spasticity in the setting of spinal cord injury. There have been no reports of the performance of spinal anesthesia in patients with a pre-existing intrathecal ...
Heath Allen, Ryu Komatsu, Hani El-Omrani
doaj   +1 more source

Intrathecal baclofen therapy and Covid-19 infection - report of three cases [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2022
Introduction. Patients with severe spasticity are effectively treated with intrathecal baclofen therapy (ITB), but because of their invalidity, in case of infection, prognosis is poor. Case outline.
Nikolić Igor   +4 more
doaj   +1 more source

Intrathecal baclofen for generalized dystonia [PDF]

open access: yesDevelopmental Medicine & Child Neurology, 2001
The aim of this study was to evaluate the effects of intrathecal bacolfen (ITB) on patients with severe generalized dystonia. Eighty‐six participants ranging in age from 3 to 42 years (median age 13 years) with generalized dystonia refractory to oral medications were offered treatment with ITB.
A L, Albright   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy